Variant report

Variant	nsv3672
Chromosome Location	chr3:331254-376000
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr3:331761-332103	GM12878	blood:	n/a	n/a
2	BATF	chr3:341729-341996	GM12878	blood:	n/a	n/a
3	BHLHE40	chr3:342270-342502	GM12878	blood:	n/a	n/a
4	CHD1	chr3:341448-341614	GM12878	blood:	n/a	n/a
5	CTCF	chr3:360820-360858	Kidney_OC	kidney:	n/a	n/a
6	CTCF	chr3:340160-340310	HUVEC	blood vessel:	n/a	n/a
7	CUX1	chr3:341633-342014	GM12878	blood:	n/a	n/a
8	EBF1	chr3:331685-332343	GM12878	blood:	n/a	n/a
9	EBF1	chr3:341471-342010	GM12878	blood:	n/a	n/a
10	EP300	chr3:360571-360892	SK-N-SH_RA	brain:	n/a	n/a
11	EP300	chr3:331603-332141	GM12878	blood:	n/a	n/a
12	EP300	chr3:332988-334291	SK-N-SH	brain:	n/a	chr3:334050-334059
13	EP300	chr3:333694-334049	SK-N-SH_RA	brain:	n/a	n/a
14	EP300	chr3:342460-342486	GM12878	blood:	n/a	n/a
15	EP300	chr3:331607-332481	GM12878	blood:	n/a	chr3:332136-332150 chr3:332216-332226
16	EP300	chr3:332793-332940	GM12878	blood:	n/a	n/a
17	EP300	chr3:360589-360901	SK-N-SH_RA	brain:	n/a	n/a
18	EP300	chr3:333737-334040	SK-N-SH_RA	brain:	n/a	n/a
19	FAM48A	chr3:354937-355056	GM12878	blood:	n/a	n/a
20	FOS	chr3:335755-336146	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr3:335789-336128	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr3:332040-332431	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr3:332199-332323	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr3:335776-336099	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr3:335744-336331	MCF10A-Er-Src	breast:	n/a	chr3:336245-336254
26	FOS	chr3:332074-332391	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr3:332043-332414	MCF10A-Er-Src	breast:	n/a	n/a
28	FOXM1	chr3:331656-332039	GM12878	blood:	n/a	n/a
29	GATA2	chr3:339416-339707	SH-SY5Y	brain:	n/a	chr3:339560-339569 chr3:339552-339562
30	GATA2	chr3:333549-334093	SH-SY5Y	brain:	n/a	n/a
31	GATA3	chr3:333659-334107	SH-SY5Y	brain:	n/a	n/a
32	GATA3	chr3:339479-339764	SH-SY5Y	brain:	n/a	chr3:339560-339569 chr3:339552-339562
33	GATA3	chr3:333630-334142	SK-N-SH	brain:	n/a	n/a
34	IKZF1	chr3:341522-341997	GM12878	blood:	n/a	n/a
35	IKZF1	chr3:331698-331990	GM12878	blood:	n/a	n/a
36	IRF1	chr3:354699-354829	K562	blood:	n/a	n/a
37	IRF1	chr3:371993-372007	K562	blood:	n/a	n/a
38	JUN	chr3:332854-333046	HepG2	liver:	n/a	chr3:332964-332973 chr3:332960-332973
39	JUN	chr3:358733-359051	HepG2	liver:	n/a	chr3:358882-358891 chr3:358878-358891
40	JUND	chr3:358719-359065	HepG2	liver:	n/a	chr3:358882-358891 chr3:358851-358862
41	MAFF	chr3:367223-367524	HepG2	liver:	n/a	chr3:367357-367375
42	MAFF	chr3:367279-367485	K562	blood:	n/a	chr3:367357-367375
43	MAFF	chr3:333423-334000	HepG2	liver:	n/a	chr3:333829-333847
44	MAFF	chr3:333738-333950	K562	blood:	n/a	chr3:333829-333847
45	MAFK	chr3:333395-334011	IMR90	lung:	n/a	chr3:333830-333844 chr3:333680-333691 chr3:333832-333852 chr3:333530-333545 chr3:333835-333849 chr3:333831-333842 chr3:333832-333843 chr3:333831-333847 chr3:333530-333546 chr3:333832-333843 chr3:333681-333692 chr3:333831-333842
46	MAFK	chr3:333750-333885	Hela-S3	cervix:	n/a	chr3:333830-333844 chr3:333832-333852 chr3:333835-333849 chr3:333831-333842 chr3:333832-333843 chr3:333831-333847 chr3:333832-333843 chr3:333831-333842
47	MAFK	chr3:333397-333979	HepG2	liver:	n/a	chr3:333830-333844 chr3:333680-333691 chr3:333832-333852 chr3:333530-333545 chr3:333835-333849 chr3:333831-333842 chr3:333832-333843 chr3:333831-333847 chr3:333530-333546 chr3:333832-333843 chr3:333681-333692 chr3:333831-333842
48	MAFK	chr3:367204-367516	HepG2	liver:	n/a	chr3:367359-367374
49	MAFK	chr3:333368-334000	HepG2	liver:	n/a	chr3:333830-333844 chr3:333680-333691 chr3:333832-333852 chr3:333530-333545 chr3:333835-333849 chr3:333389-333400 chr3:333387-333401 chr3:333831-333842 chr3:333832-333843 chr3:333831-333847 chr3:333530-333546 chr3:333832-333843 chr3:333681-333692 chr3:333831-333842
50	MAFK	chr3:367282-367482	H1-hESC	embryonic stem cell:	n/a	chr3:367359-367374

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:350602-350652	BJ	skin:	n/a
2	chr3:350602-350652	BJ	skin:	n/a
3	chr3:350789-350839	Jurkat	blood:	n/a
4	chr3:350789-350839	ovcar-3	ovarian:	n/a
5	chr3:350892-350942	HRE	kidney:	n/a
6	chr3:347869-347919	K562	blood:	n/a
7	chr3:350682-350732	GM12891	blood:	n/a
8	chr3:351003-351053	LNCaP	prostate:	n/a
9	chr3:347869-347919	NH-A	brain:	n/a
10	chr3:351003-351053	HAEpiC	amniotic membrane:	n/a
11	chr3:350503-350553	NT2-D1	testis:	n/a
12	chr3:350892-350942	H1-hESC	embryonic stem cell:	embryo
13	chr3:351003-351053	PFSK-1	brain:	n/a
14	chr3:350892-350942	HUVEC	blood vessel:	n/a
15	chr3:351003-351053	HIPEpiC	eye:	n/a
16	chr3:347869-347919	MCF10A-Er-Src	breast:	n/a
17	chr3:347869-347919	PANC-1	pancreas:	n/a
18	chr3:350503-350553	HPAEpiC	pulmonary alveolar:	n/a
19	chr3:350682-350732	NH-A	brain:	n/a
20	chr3:350892-350942	HCM	heart:	n/a
21	chr3:350789-350839	Hepatocyte	liver:	n/a
22	chr3:350503-350553	ovcar-3	ovarian:	n/a
23	chr3:350892-350942	BJ	skin:	n/a
24	chr3:353166-353216	HEEpiC	esophagus:	n/a
25	chr3:353166-353216	NH-A	brain:	n/a
26	chr3:353166-353216	H1-hESC	embryonic stem cell:	embryo
27	chr3:353166-353216	IMR90	lung:	fetal
28	chr3:353166-353216	SKMC	muscle:	n/a
29	chr3:347869-347919	HepG2	liver:	n/a
30	chr3:347869-347919	SK-N-MC	brain:	n/a
31	chr3:350503-350553	ECC-1	luminal epithelium:	n/a
32	chr3:350789-350839	BE2_C	brain:	n/a
33	chr3:350892-350942	K562	blood:	n/a
34	chr3:353166-353216	PFSK-1	brain:	n/a
35	chr3:353166-353216	HCT-116	colon:	n/a
36	chr3:347869-347919	H1-hESC	embryonic stem cell:	embryo
37	chr3:347869-347919	GM19239	blood:	n/a
38	chr3:353166-353216	GM12891	blood:	n/a
39	chr3:350602-350652	HRE	kidney:	n/a
40	chr3:351003-351053	SKMC	muscle:	n/a
41	chr3:353166-353216	Hela-S3	cervix:	n/a
42	chr3:350602-350652	ovcar-3	ovarian:	n/a
43	chr3:347869-347919	HEEpiC	esophagus:	n/a
44	chr3:351003-351053	Hela-S3	cervix:	n/a
45	chr3:350682-350732	AG04450	lung:	fetal
46	chr3:350892-350942	MCF10A-Er-Src	breast:	n/a
47	chr3:347869-347919	IMR90	lung:	fetal
48	chr3:350892-350942	AG09309	skin:	n/a
49	chr3:350789-350839	AG10803	skin:	n/a
50	chr3:351003-351053	AG04449	skin:	fetal

No.	Distal block	Cell Line	Cell type
1	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:
2	chr3:369627..372241-chr3:375088..376630,2	K562	blood:
3	chr3:321596..323780-chr3:337949..340526,2	MCF-7	breast:
4	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:
5	chr3:369627..372241-chr3:375088..376630,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IL5RA-15	chr3:350397-351005	NONHSAT087564

Variant related genes	Relation type
RPS8P6	TF binding region
CHL1	TF binding region
RPS8P6	CpG island
CHL1	CpG island

Extended variants
information (count: 2067 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:2067 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187878211	chr3:331272-331273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs563647698	chr3:331297-331298	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs530946191	chr3:331307-331308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs147965932	chr3:331313-331314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs141728084	chr3:331315-331316	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs113451567	chr3:331352-331353	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs191229322	chr3:331390-331391	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs547831536	chr3:331408-331409	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs546760938	chr3:331419-331420	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs558814062	chr3:331425-331426	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs332450	chr3:331429-331430	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs535693202	chr3:331436-331437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs556858140	chr3:331465-331466	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs553528556	chr3:331472-331473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs574858137	chr3:331512-331513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs539025949	chr3:331542-331543	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs557379321	chr3:331551-331552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs572886075	chr3:331572-331573	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs535769873	chr3:331578-331579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs374879491	chr3:331615-331616	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs201687696	chr3:331622-331623	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs4054794	chr3:331635-331636	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs539961814	chr3:331639-331640	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs34294527	chr3:331665-331666	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs559854906	chr3:331712-331713	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs553337894	chr3:331719-331720	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs644934	chr3:331723-331724	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs147100453	chr3:331774-331775	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs531258101	chr3:331818-331819	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs575942219	chr3:331851-331852	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs371856509	chr3:331857-331858	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs552599979	chr3:331858-331859	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs564361671	chr3:331860-331861	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs182259889	chr3:331885-331886	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs369532227	chr3:331914-331915	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs147691413	chr3:331967-331968	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs35960647	chr3:331982-331983	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs114965855	chr3:331992-331993	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs568217465	chr3:332012-332013	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs535282299	chr3:332032-332033	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs188159273	chr3:332037-332038	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs573272307	chr3:332065-332066	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs568809089	chr3:332076-332077	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs557874269	chr3:332103-332104	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs149154270	chr3:332159-332160	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs572755554	chr3:332173-332174	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs192726841	chr3:332181-332182	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs143292578	chr3:332205-332206	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs185037530	chr3:332238-332239	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs377109285	chr3:332242-332243	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD

Chromatin state (count:103 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:326400-331600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr3:326600-336200	Weak transcription	Fetal Brain Female	brain
3	chr3:330000-334400	Weak transcription	Esophagus	oesophagus
4	chr3:330400-331600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr3:330600-331800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr3:331000-331800	Enhancers	Primary B cells from cord blood	blood
7	chr3:331000-334000	Enhancers	Primary B cells from peripheral blood	blood
8	chr3:331400-331600	Enhancers	GM12878-XiMat	blood
9	chr3:331600-331800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr3:331600-332200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr3:331600-332400	Flanking Active TSS	GM12878-XiMat	blood
12	chr3:331800-332200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr3:331800-332400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr3:331800-332400	Flanking Active TSS	Primary B cells from cord blood	blood
15	chr3:332200-332400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr3:332400-332600	Enhancers	Small Intestine	intestine
17	chr3:332400-333000	Enhancers	GM12878-XiMat	blood
18	chr3:332400-333400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr3:332400-333600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr3:332400-333800	Enhancers	Primary B cells from cord blood	blood
21	chr3:333200-334000	Enhancers	Pancreatic Islets	Pancreatic Islet
22	chr3:333400-334000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr3:333400-334000	Enhancers	Colon Smooth Muscle	Colon
24	chr3:333400-334400	Enhancers	Fetal Lung	lung
25	chr3:333800-334000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr3:333800-338800	Weak transcription	Primary B cells from cord blood	blood
27	chr3:334000-338200	Weak transcription	Primary B cells from peripheral blood	blood
28	chr3:334200-334400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
29	chr3:334400-334600	ZNF genes & repeats	Ganglion Eminence derived primary cultured neurospheres	brain
30	chr3:334400-335800	Enhancers	Esophagus	oesophagus
31	chr3:334600-336400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr3:335800-337000	Enhancers	NHEK	skin
33	chr3:336200-336800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr3:336400-337600	Enhancers	Cortex derived primary cultured neurospheres	brain
35	chr3:336400-337800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr3:336800-337400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr3:338200-340600	Enhancers	Primary B cells from peripheral blood	blood
38	chr3:338800-340400	Enhancers	Primary B cells from cord blood	blood
39	chr3:339400-339800	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr3:340600-341000	Weak transcription	Primary B cells from peripheral blood	blood
41	chr3:341000-341200	Enhancers	Primary B cells from peripheral blood	blood
42	chr3:341200-343000	Weak transcription	Primary B cells from peripheral blood	blood
43	chr3:343000-343200	Enhancers	Primary B cells from peripheral blood	blood
44	chr3:343000-343200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
45	chr3:343200-343600	Weak transcription	Primary B cells from peripheral blood	blood
46	chr3:348600-349000	Enhancers	Fetal Brain Female	brain
47	chr3:348800-349200	Enhancers	Fetal Brain Male	brain
48	chr3:349000-350600	Weak transcription	Fetal Brain Female	brain
49	chr3:349200-350400	Weak transcription	Fetal Brain Male	brain
50	chr3:350400-350600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links